网站大量收购独家精品文档,联系QQ:2885784924

Prevention of childhood respiratory pidotimod Efficacy of re-infection.doc

Prevention of childhood respiratory pidotimod Efficacy of re-infection.doc

  1. 1、本文档共5页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Prevention of childhood respiratory pidotimod Efficacy of re-infection

 PAGE \* MERGEFORMAT 5 Prevention of childhood respiratory pidotimod Efficacy of re-infection [Keywords:] children with respiratory tract infections, treatment Pediatric respiratory tract infections are common disease in children during the relevant organs of the body is not perfect organizational structure and development, immune dysfunction, respiratory disease caused by recurrent high. To find an effective immunomodulatory treatment, reduce re-infection of respiratory tract, our department since January 2007 to October 2008, the choice of pidotimod (Fu-exposed children to drink oral liquid for prevention of respiratory tract infection, a significant effect, are summarized as follows. 1 Materials and Methods 1.1 Case Selection Selection criteria: hospital pediatric clinic or hospital to cure children with respiratory tract infection in 32 cases (no malnutrition and congenital immune deficiencies and other underlying diseases, age 6 months to 8 years old, 17 males and 15 females an average of 3.6 years. Diseases: Congenital heart disease in 4 cases of pneumonia, pneumonia in 16 cases, 10 cases of recurrent upper respiratory tract infection, asthma with lower respiratory tract infection in 2 cases. 1.2 Experimental Methods and Statistics observed cases within 6 months before and after treatment the number of respiratory tract infection and disease spectrum, check the blood before and after administration of each case, C-reactive protein, immunoglobulin and T cell subsets. Guidance in all cases a reasonable diet, sequential vaccination, to maintain the same living environment, added in the pidotimod (Jiangsu Wuzhong pharmaceutical company, lot number 090103 oral, both with a course of 2 months. Pidotimod dose:gt; 3 years, 1 month 400 mg bid, po, the first 2 months 400 mg qd, po, lt;3 years, 1 month 200 mg bid, po, the first 2 months 200 mg qd, po. 2 Results 2.1 The results shown in Table 1, Table 2. 2.2 All cases of adverse drug reacti

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档